Sotera Health Co (SHC)
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Sector: Services-Misc Health & Allied Services, NEC
Industry: Medical - Diagnostics & Research
Sotera Health Company
NASDAQ:SHCHealthcare · Medical - Diagnostics & Research
-0.17%$18.10
AH Close$18.10+0.00%vs close
AH Close$18.10+0.00%vs close
Mkt Cap$5.17B
Float265.58M
O/S285.37M
Inst Own-
SI5.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$1.16B
Net Income$77.95M
Total Assets$3.26B
Free Cash Flow$149.18M
Debt & Equity
Debt 79%
Equity 21%
Total Debt$2.27B
Total Equity$606.03M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SHC's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$3.26B
Liabilities$2.66B
Accounts Receivable$176.27M
Accounts Payable$77.96M
Inventory$59.39M
PP&E (Net)$1.16B
Goodwill$1.1B
Intangible Assets$288.23M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $1.16B | $1.1B | $1.05B | $1B | $931.48M | $818.16M | $778.33M | $746.15M |
| YoY Growth | 5.7% | 4.9% | 4.5% | 7.8% | 13.9% | 5.1% | 4.3% | - |
| Cost of Revenue | $518.08M | $498.15M | $472.13M | $446.68M | $412.81M | $374.59M | $382.9M | $388.9M |
| Gross Profit | $645.53M | $602.29M | $577.16M | $557M | $518.67M | $443.57M | $395.43M | $357.25M |
| Gross Margin | 55.5% | 54.7% | 55.0% | 55.5% | 55.7% | 54.2% | 50.8% | 47.9% |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $252.76M | $242.63M | $236.67M | $245.71M | $198.16M | $178.53M | $147.48M | $133.36M |
| Other | $0 | $62.04M | $63.8M | $62.94M | $63.78M | $59.03M | $64.35M | $143.04M |
| Total Operating Expenses | $252.76M | $304.67M | $300.47M | $308.65M | $261.94M | $237.55M | $211.83M | $191.34M |
| Operating Income (EBIT) | $392.77M | $297.63M | $276.69M | $248.35M | $256.73M | $206.02M | $183.6M | $80.85M |
| Operating Margin | 33.8% | 27.0% | 26.4% | 24.7% | 27.6% | 25.2% | 23.6% | 10.8% |
| Interest Expense | $155.72M | $164.69M | $142.88M | $80.14M | $74.19M | $215.26M | $157.73M | $143.33M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$245.27M | -$183.75M | -$170.66M | -$491.46M | -$81.02M | -$244.88M | -$184.51M | -$56.63M |
| Income Before Tax (EBT) | $147.51M | $113.87M | $106.03M | -$243.11M | $175.72M | -$38.86M | -$916K | $24.22M |
| Income Tax Expense | $69.56M | $69.48M | $54.65M | -$9.54M | $58.59M | -$1.37M | $19.51M | $30.1M |
| Net Income | $77.95M | $44.4M | $51.38M | -$233.57M | $116.88M | -$38.62M | -$20.85M | -$5.87M |
| Net Income Margin | 6.7% | 4.0% | 4.9% | -23.3% | 12.5% | -4.7% | -2.7% | -0.8% |
| Supplementary Data | ||||||||
| EPS | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.14 | -0.07 | -0.02 |
| Diluted EPS | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.14 | -0.07 | -0.02 |
| Weighted Average OS | 283.96M | 282.78M | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
| EBITDA | $442.25M | $442.2M | $406.83M | -$17.41M | $400.81M | $319.96M | $303.53M | $314.36M |
| EBITDA Margin | 38.0% | 40.2% | 38.8% | -1.7% | 43.0% | 39.1% | 39.0% | 42.1% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $346.46M | $277.24M | $296.41M | $395.21M | $106.92M | $102.45M | $62.86M | $96.27M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $346.46M | $277.24M | $296.41M | $395.21M | $106.92M | $102.45M | $62.86M | $96.27M |
| Accounts Receivable | $176.27M | $165.81M | $175.52M | $155.72M | $134.05M | $131.02M | $111.58M | $141.61M |
| Inventory | $59.39M | $49.16M | $48.32M | $37.15M | $54.29M | $34.09M | $37.4M | $37.6M |
| Other Current Assets | $14.5M | $16.58M | $20.91M | $16.56M | $11.19M | $10.74M | $10.84M | $12.15M |
| Total Current Assets | $613.41M | $526.04M | $557.24M | $645.01M | $345.96M | $315.01M | $252.35M | $312.86M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $1.16B | $1.06B | $970.95M | $801.01M | $690.74M | $655.78M | $581.95M | $586.44M |
| Goodwill | $1.1B | $1.08B | $1.11B | $1.1B | $1.12B | $1.12B | $1.04B | $1.02B |
| Intangible Assets | $288.23M | $317.65M | $416.32M | $491.26M | $598.84M | $643.37M | $696.01M | $766.05M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $9.4M | $13.46M | $0 | $0 |
| Deferred Tax Assets | $3.85M | $2.87M | $4.99M | $4.1M | $5.88M | $8.42M | $2.25M | $15.76M |
| Other Long-Term Assets | $90.51M | $79.58M | $69.72M | $74.55M | $18.34M | $9.3M | $12.24M | $4.15M |
| Total Long-Term Assets | $2.65B | $2.55B | $2.57B | $2.47B | $2.44B | $2.45B | $2.33B | $2.4B |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B | $2.76B | $2.58B | $2.71B |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $77.96M | $55.1M | $71.04M | $74.14M | $72.87M | $52.4M | $42M | $46.35M |
| Short-Term Debt | $23.19M | $14.8M | $4.8M | $197.12M | $0 | $0 | $16.33M | $15.34M |
| Current Income Tax Payable | $0 | $11.48M | $6.56M | $8.43M | $8.9M | $13.05M | $2.36M | $2.65M |
| Current Unearned Revenue | $18M | $15.1M | $13.49M | $12.14M | $8.67M | $6.06M | $3.63M | $4.62M |
| Other Current Liabilities | $81.19M | $41.12M | $36.93M | $43.12M | $37.21M | $38.8M | $37.34M | $50.65M |
| Total Current Liabilities | $249.58M | $191M | $230.65M | $791.57M | $161.16M | $140.6M | $123.99M | $143.37M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $2.13B | $2.21B | $2.22B | $1.75B | $1.74B | $1.82B | $2.8B | $2.19B |
| Long-Term Unearned Revenue | $17.06M | $16.78M | $18.76M | $18.9M | $20.75M | $21.25M | $21.38M | $20.95M |
| Long-Term Deferred Tax Liabilities | $71.08M | $69.5M | $64.45M | $68.02M | $134.5M | $121.82M | $137.24M | $171.48M |
| Other Long-Term Liabilities | $68.98M | $61.6M | $65.26M | $63.33M | $69.57M | $124.37M | $108.45M | $106.18M |
| Total Long-Term Liabilities | $2.41B | $2.48B | $2.46B | $1.98B | $2.04B | $2.17B | $3.1B | $2.52B |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.66B | $2.67B | $2.69B | $2.77B | $2.2B | $2.31B | $3.22B | $2.66B |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $2.86M | $2.86M | $2.86M | $2.86M | $2.86M | $2.86M | $2.32M | $2.32M |
| Retained Earnings | -$532.09M | -$610.04M | -$654.44M | -$705.82M | -$472.25M | -$589.13M | -$550.51M | -$10.42M |
| Comprehensive Income & Other | -$109.84M | -$208.25M | -$92.68M | -$106.65M | -$83.57M | -$93.84M | -$94.39M | -$109.96M |
| Other Stockholders' Equity | $1.14B | $1.01B | $1.1B | $1.05B | $1.06B | $1.04B | -$94.39M | $52.45M |
| Total Equity | $606.03M | $404.91M | $443.73M | $350.24M | $586.1M | $452.3M | -$642.57M | $44.36M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $2.27M | $1.44M | $1.13M |
| Total Liabilities and Equity | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B | $2.76B | $2.58B | $2.71B |
| Supplementary Data | ||||||||
| Total Debt | $2.27B | $2.35B | $2.33B | $2.03B | $1.83B | $1.91B | $2.85B | $2.24B |
| Net Debt | $1.93B | $2.07B | $2.03B | $1.64B | $1.72B | $1.81B | $2.79B | $2.14B |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | $77.95M | $44.4M | $51.38M | -$233.57M | $117.12M | -$37.49M | -$20.43M | -$5.88M |
| Depreciation & Amortization | $139.03M | $163.64M | $157.93M | $145.55M | $150.9M | $143.56M | $146.72M | $146.82M |
| Deferred Income Tax | $22K | $9.43M | $3.45M | -$73.96M | -$3.72M | -$23.36M | -$18.99M | -$45.32M |
| Stock-Based Compensation | $30.88M | $36.78M | $32.24M | $21.21M | $13.87M | $10.99M | $6.88M | $6.94M |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $7.15M | $2.22M | -$21.72M | -$12.55M | -$15.51M | $1.94M | $11.76M | -$2.91M |
| Inventory | -$2.38M | -$4.75M | -$9.97M | $14.44M | -$20.25M | $3.78M | -$282K | -$7.04M |
| Accounts Payable | $5.18M | -$6.64M | -$5.33M | $1.11M | $19.76M | -$6.02M | -$8.97M | $15.13M |
| Other Working Capital | $18.09M | -$33.45M | -$366.26M | $406.24M | $3.4M | -$11.5M | -$10.87M | -$1.14M |
| Total Working Capital Change | $28.04M | -$42.63M | -$403.29M | $409.23M | -$12.59M | -$11.79M | -$8.35M | $4.04M |
| Other Non-Cash Items | $11.28M | $12.55M | $10.56M | $9.49M | $15.96M | $38.68M | $43.21M | $12.96M |
| Net Cash from Operating | $287.19M | $224.16M | -$147.73M | $277.96M | $281.55M | $120.58M | $149.04M | $119.56M |
| Investing Activities | ||||||||
| Capital Expenditures | -$138.02M | -$179.07M | -$214.97M | -$182.38M | -$102.16M | -$53.51M | -$57.26M | -$72.61M |
| Acquisitions | $0 | $0 | $0 | $450K | -$56.97M | -$105.19M | $0 | $162.82M |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $2.87M | $74K | $69K | $32K | -$701K | $0 | $0 | $6.43M |
| Net Cash from Investing | -$135.14M | -$179M | -$214.91M | -$181.9M | -$159.83M | -$158.69M | -$57.26M | $96.64M |
| Financing Activities | ||||||||
| Debt Repaid | $86.1M | -$2.25B | -$500M | -$200M | $100M | $1.03B | -$583.52M | $14.63M |
| Common Stock Issuance | -$6.57M | $0 | $0 | $0 | $0 | $1.16B | $0 | $0 |
| Common Stock Repurchases | $0 | -$4.43M | -$4.09M | -$393K | -$1.43M | -$34M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | -$691.17M | -$175.84M |
| Other Financing Activities | -$7.86M | -$34.38M | -$27.45M | -$1.85M | -$15.85M | -$21.2M | -$18.38M | -$1.38M |
| Net Cash from Financing | -$100.53M | -$50.56M | $265.96M | $197.76M | -$117.29M | $73.43M | -$126.03M | -$191.86M |
| Forex Effect | $16.07M | -$17.39M | $2.04M | -$4.46M | $44K | $4.11M | $485K | -$3.68M |
| Net Change in Cash | $67.59M | -$22.79M | -$94.64M | $289.37M | $4.47M | $39.43M | -$33.76M | $20.67M |
| Supplementary Data | ||||||||
| Operating Cash Flow | $287.19M | $224.16M | -$147.73M | $277.96M | $281.55M | $120.58M | $149.04M | $119.56M |
| Capital Expenditure | -$138.02M | -$179.07M | -$214.97M | -$182.38M | -$102.16M | -$53.51M | -$57.26M | -$72.61M |
| Free Cash Flow | $149.18M | $45.09M | -$362.71M | $95.58M | $179.38M | $67.08M | $91.78M | $46.95M |
| Cash at Beginning | $278.87M | $301.65M | $396.29M | $106.92M | $102.45M | $63.02M | $96.79M | $76.12M |
| Cash at End | $346.46M | $278.87M | $301.65M | $396.29M | $106.92M | $102.45M | $63.02M | $96.79M |